US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

AQR Capital Holdings

1,798.29

+10.430.58%

Number of Gainers:73

Number of Losers:24

Number of Flat:- -

PE:- -

High:1,802.86

Open:1,787.27

Low:1,765.89

Close:1,787.85

Loading ...

Vertex Pharmaceuticals Inc - Working With Nice and Nhs for Alyftrek Access

THOMSON REUTERS

Vertex Announces UK Mhra Approval of Alyftrek® (Deutivacaftor/Tezacaftor/Vanzacaftor), a Once-Daily Next-in-Class Cftr Modulator for the Treatment of Cystic Fibrosis

THOMSON REUTERS

Vertex Announces UK MHRA Approval of ALYFTREK® (Deutivacaftor/Tezacaftor/Vanzacaftor), a Once-Daily Next-in-Class CFTR Modulator for the Treatment of Cystic Fibrosis

Broadcom's Strong Custom Chips Biz May Quell Macro Concerns -- Market Talk

BUZZ-Jazz Pharma climbs after Morgan Stanley raises PT

Why Kroger (KR) is a Top Value Stock for the Long-Term

Alphabet (GOOGL) Stock Hovers in Buy-The-Dip Territory

Costco Shares Down About 4% After Q2 Profit Miss

THOMSON REUTERS

Analysts’ Top Consumer Goods Picks: Mama’s Creations (MAMA), Walmart (WMT)

Analysts Conflicted on These Consumer Cyclical Names: Carvana Co (CVNA), Martinrea International (OtherMRETF) and Amazon (AMZN)

Eli Lilly Says Half of Eczema Patients Achieve Complete Skin Clearance at 3 Years With Ebglyss

MT Newswires Live

Microsoft testng OpenAI alternatives for Copilot, The Information reports

SLDB Stock Rallies 60% in a Month: Here's What You Should Know

BUZZ-Neumora falls as J&J's setback triggers concerns over depression drug

Philip Morris International (PM): One of the Best Stocks to Invest In According to Billionaires

BRIEF-Humana Says CEO James A. Rechtin's 2024 Total Compensation Was $15.6 Million – SEC Filing

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/BK4533/news?page=14"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK4533"},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4533\",,,,,undefined,":{"symbol":"BK4533","market":"US","secType":"PLATE","nameCN":"AQR Capital Holdings","latestPrice":1798.2865,"timestamp":1741381199999,"preClose":1787.8518,"halted":0,"volume":1485651602,"delay":0,"changeRate":0.005836,"change":10.434692,"pbRate":6.882193,"amount":217410420798.8019,"amplitude":0.020678,"prevYearClose":1876.573,"fiveDayClose":1844.0504,"twentyDayClose":1911.6675,"turnoverRate":0.00831,"marketCap":33108112461824,"floatMarketCap":30933640783872,"peRate":27.966651},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4533\",,,,,undefined,":{"symbol":"BK4533","high":1802.8636,"amplitude":0.020678,"preClose":1787.8518,"low":1765.8937,"pbRate":"6.882193","latestPrice":1798.2865,"volume":1485651602,"delay":0,"open":1787.2693,"prevYearClose":1876.573,"prevWeekClose":1798.2865,"prevMonthClose":1844.0504,"prevQuarterClose":1876.573,"fiveDayClose":1844.0504,"twentyDayClose":1911.6675,"sixtyDayClose":1897.0826,"secType":"PLATE","market":"US","turnoverRate":0.00831,"peRate":27.966651,"marketCap":33108112461824,"floatMarketCap":30933640783872,"timestamp":1741381199999,"nameCN":"AQR Capital Holdings"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4533\",,,,undefined,":{"bkCode":"BK4533","up":73,"down":24,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4533\",pageSize:16,pageCount:14,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2517431273","title":"Vertex Pharmaceuticals Inc - Working With Nice and Nhs for Alyftrek Access","url":"https://stock-news.laohu8.com/highlight/detail?id=2517431273","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517431273?lang=en_us&edition=fundamental","pubTime":"2025-03-07 23:02","pubTimestamp":1741359720,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250307:nTUA7VCKSK:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0061475181.USD","LU0109394709.USD","LU1093756325.SGD","LU2236285917.USD","BK4533","BK4139","LU2456880835.USD","BK4567","IE0002141913.USD","LU1093756168.USD","LU2362540622.SGD","LU1069344957.HKD","LU2462157665.USD","LU2362541513.USD","IE00B894F039.SGD","IE00BFTCPJ56.SGD","IE00B19Z9Z06.USD","IE00B4R5TH58.HKD","LU0289739699.SGD","BK4585","LU1585245621.USD","LU1035775433.USD","LU2417539215.USD","IE00B19Z3B42.SGD","LU0823416689.USD","LU0058720904.USD","IE0002270589.USD","IE00BZ9MQY76.HKD","IE00BJJMRZ35.SGD","LU2237438978.USD","LU0079474960.USD","LU2324357040.USD","BK4588","IE00B19Z3581.USD","IE00B19Z9P08.USD","LU0320765992.SGD","VRTX","IE00B2B36J28.USD","IE00BJT1NW94.SGD","LU0234570918.USD","LU2362541273.HKD","IE0009355771.USD","LU0417517546.SGD","LU1430594728.SGD","LU0256863811.USD","LU0889565916.HKD","BK4532"],"gpt_icon":0},{"id":"2517312774","title":"Vertex Announces UK Mhra Approval of Alyftrek® (Deutivacaftor/Tezacaftor/Vanzacaftor), a Once-Daily Next-in-Class Cftr Modulator for the Treatment of Cystic Fibrosis","url":"https://stock-news.laohu8.com/highlight/detail?id=2517312774","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517312774?lang=en_us&edition=fundamental","pubTime":"2025-03-07 23:02","pubTimestamp":1741359720,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250307:nTUA7VCKSK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1093756168.USD","IE00BJJMRZ35.SGD","LU0889565916.HKD","IE00B19Z9P08.USD","IE00BFTCPJ56.SGD","LU0417517546.SGD","IE00B4R5TH58.HKD","LU0061475181.USD","IE0002141913.USD","IE00B19Z9Z06.USD","LU1035775433.USD","IE00B2B36J28.USD","IE00BJT1NW94.SGD","IE00B19Z3581.USD","BK4585","LU2236285917.USD","LU2456880835.USD","IE00B894F039.SGD","BK4532","IE00B19Z3B42.SGD","LU0289739699.SGD","LU0320765992.SGD","LU0234570918.USD","LU1069344957.HKD","LU2324357040.USD","LU2362540622.SGD","IE0009355771.USD","LU0058720904.USD","LU1430594728.SGD","LU2417539215.USD","LU1093756325.SGD","VRTX","LU2362541273.HKD","LU1585245621.USD","LU0256863811.USD","LU2237438978.USD","BK4567","BK4588","IE00BZ9MQY76.HKD","BK4139","LU0079474960.USD","LU0109394709.USD","LU0823416689.USD","LU2362541513.USD","BK4533","IE0002270589.USD","LU2462157665.USD"],"gpt_icon":0},{"id":"2517432352","title":"Vertex Announces UK MHRA Approval of ALYFTREK® (Deutivacaftor/Tezacaftor/Vanzacaftor), a Once-Daily Next-in-Class CFTR Modulator for the Treatment of Cystic Fibrosis","url":"https://stock-news.laohu8.com/highlight/detail?id=2517432352","media":"Business Wire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517432352?lang=en_us&edition=fundamental","pubTime":"2025-03-07 23:02","pubTimestamp":1741359720,"startTime":"0","endTime":"0","summary":"\"For more than 20 years we have been focused on discovering medicines that treat the underlying cause of the disease with the goal of helping people live longer and better lives. The approval of ALYFTREK, our fifth CFTR modulator regimen, represents another significant milestone in that journey for people with CF in the UK,\" said Carmen Bozic, M.D., Executive Vice President, Global Medicines Development and Medical Affairs, and Chief Medical Officer at Vertex.Vertex is working with the National Institute for Health and Care Excellence  and the NHS to ensure eligible patients can access this new therapy, which treats the underlying cause of CF, as soon as possible.Cystic fibrosis  is a rare, life-shortening genetic disease affecting more than 94,000 people in North America, Europe and Australia. CF is a progressive, multi-organ disease that affects the lungs, liver, pancreas, GI tract, sinuses, sweat glands and reproductive tract. CF is caused by a defective and/or missing CFTR protein ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/vertex-announces-uk-mhra-approval-150200748.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU1035775433.USD","BK4138","LU1093756168.USD","LU0061475181.USD","IE00B19Z9P08.USD","IE00B894F039.SGD","LU0256863811.USD","BK4139","LU0234570918.USD","LU0566484027.USD","IE00BFMHRM44.USD","LU2324357040.USD","BK4233","NICE","LU0417517546.SGD","VERX","IE00B19Z9Z06.USD","IE00BFTCPJ56.SGD","LU0289739699.SGD","LU0823416689.USD","LU2362541513.USD","LU2462157665.USD","BK4588","BK4566","BK4533","BK4205","LU2362540622.SGD","LU2362541273.HKD","IE00BJJMRZ35.SGD","LU2456880835.USD","LU0109394709.USD","IE00BZ9MQY76.HKD","LU2237438978.USD","LU1815336091.USD","BK4528","CF","LU0058720904.USD","BK4093","LU2236285917.USD","IE00B19Z3581.USD","LU1430594728.SGD","UK","LU0757428866.USD","BK4585","VRTX","IE0002270589.USD","BK4543","LU1069344957.HKD","VTNR","LU0889565916.HKD"],"gpt_icon":0},{"id":"2517434328","title":"Broadcom's Strong Custom Chips Biz May Quell Macro Concerns -- Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2517434328","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517434328?lang=en_us&edition=fundamental","pubTime":"2025-03-07 22:45","pubTimestamp":1741358700,"startTime":"0","endTime":"0","summary":"0945 ET - Broadcom is facing plenty of headwinds, particularly from the Trump administration's trade war and potential limits on AI chip exports, but the company seems confident that its dominance on custom chip sales should keep it moving in the right direction, Melius Research analysts say in a research note. It has a growing base of elite custom ASIC chip customers, they say. Broadcom makes a compelling argument that application-custom chips for AI will continue to proliferate, including specific accelerators of aspects of training and inferencing, the analysts say. ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0444971666.USD","LU2279689827.SGD","LU0661504455.SGD","LU1732799900.SGD","IE00BKDWB100.SGD","LU2357305700.SGD","AVGOP","LU1037948897.HKD","LU1551013425.SGD","LU2430703095.HKD","LU2361044949.HKD","LU2087625088.SGD","BK4533","LU0683600562.USD","LU0157215616.USD","LU1003077747.HKD","LU2505996509.AUD","LU2473716301.USD","AVGO","BK4612","LU0957791311.USD","LU2237443465.HKD","IE00BGHQDM52.EUR","IE00B19Z9P08.USD","LU2237957902.USD","IE00BJLML261.HKD","LU0476273544.USD","LU2237443382.USD","SG9999002232.USD","IE00B3PB1722.GBP","LU2322448957.HKD","LU0417517546.SGD","LU0079474960.USD","LU0949170772.SGD","LU1720051108.HKD","BK4551","IE00BGHQF631.EUR","LU1642822529.SGD","LU1935043023.USD","LU0256863902.USD","LU0053666078.USD","LU2750360641.GBP","LU2211815571.USD","IE00BWXC8680.SGD","IE00B5949003.HKD","LU0127658192.USD","LU0466842654.USD","LU2458330169.SGD","LU0795875169.SGD","LU0096362180.USD"],"gpt_icon":1},{"id":"2517143920","title":"BUZZ-Jazz Pharma climbs after Morgan Stanley raises PT","url":"https://stock-news.laohu8.com/highlight/detail?id=2517143920","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517143920?lang=en_us&edition=fundamental","pubTime":"2025-03-07 22:43","pubTimestamp":1741358628,"startTime":"0","endTime":"0","summary":"BUZZ-Jazz Pharma climbs after Morgan Stanley raises PT** Jazz Pharmaceuticals' JAZZ.O shares rise 3% to $141.29** Brokerage Morgan Stanley raises PT to $183 from $175, a 34.1% upside to the stock's last close; maintains \"overweight\" rating** Says growth of Jazz's newer sleep disorder drug Xywav in H1 should offset ongoing switch from older drug Xyrem** Sees 'meaningful expansion' opportunity for Jazz's breast cancer drug Ziihera** Brokerage expects peak annual revenue of $240 million for brain tumor drug dordaviprone, Jazz's newly acquired drug from its buyout of Chimerix CMRX.O ** Six brokerages rate the stock \"buy\" or equivalent, one \"neutral\"; their median PT is $187.47, according to data compiled by LSEG** JAZZ has risen 16.4% in the past 12 months  ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250307:nL3N3PQ183:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","IE00BN0W2V16.EUR","IE00BN0W2T93.GBP","BK4583","LU0109394709.USD","LU0889565916.HKD","LU0823416689.USD","JAZZ","IE00BN0W2W23.USD","BK4532","CMRX","LU0320765992.SGD","BK4007","BK4533"],"gpt_icon":0},{"id":"2517445392","title":"Why Kroger (KR) is a Top Value Stock for the Long-Term","url":"https://stock-news.laohu8.com/highlight/detail?id=2517445392","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517445392?lang=en_us&edition=fundamental","pubTime":"2025-03-07 22:40","pubTimestamp":1741358408,"startTime":"0","endTime":"0","summary":"For new and old investors, taking full advantage of the stock market and investing with confidence are common goals.Many investors also have a go-to methodology that helps guide their buy and sell decisions. One way to find winning stocks based on your preferred way of investing is to use the Zacks Style Scores, which are indicators that rate stocks based on three widely-followed investing types: value, growth, and momentum.Why Investors Should Pay Attention to This Value Stock. Different than growth or momentum investors, value-focused investors are all about finding good stocks at good prices, and discovering which companies are trading under what their true value is before the broader market catches on. The Value Style Score utilizes ratios like P/E, PEG, Price/Sales, and Price/Cash Flow to help pick out the most attractive and discounted stocks.Many value investors pay close attention to a company's earnings as well. For KR, four analysts revised their earnings estimate upwards in ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/why-kroger-kr-top-value-144008176.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4113","BK4533","LU0130102774.USD","LU0130517989.USD","KR","BK4585","LU0345770993.USD","BK4559","LU0302445910.USD","LU0477156953.USD","LU0345770308.USD","LU0312595415.SGD","BK4504","LU0648001328.SGD","BK4588","LU1201861249.SGD","LU2275660780.HKD","LU0980610538.SGD","BK4532"],"gpt_icon":0},{"id":"2517439463","title":"Alphabet (GOOGL) Stock Hovers in Buy-The-Dip Territory","url":"https://stock-news.laohu8.com/highlight/detail?id=2517439463","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517439463?lang=en_us&edition=fundamental","pubTime":"2025-03-07 22:35","pubTimestamp":1741358116,"startTime":"0","endTime":"0","summary":"Since early February, when Google-parent company Alphabet ($GOOGL) reported its Q4 results, the stock has been treading water, significantly underp...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/article/alphabet-googl-stock-hovers-in-buy-the-dip-territory?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/article/alphabet-googl-stock-hovers-in-buy-the-dip-territory?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0096362180.USD","LU1366333091.USD","LU1069344957.HKD","LU2357305700.SGD","LU1059921491.USD","LU0640476718.USD","BK4574","GOOG","LU0792757196.USD","BK4573","LU2326559502.SGD","LU0708994859.HKD","LU1868837300.USD","LU0068578508.USD","LU2552382058.USD","SG9999000418.SGD","LU2420271590.USD","IE00B775SV38.USD","BK4534","IE00BJTD4V19.USD","LU0289960550.SGD","LU1496350502.SGD","LU0861579265.USD","LU2092627202.USD","LU2491050154.USD","LU2023251221.USD","LU1046421795.USD","LU1642822529.SGD","LU2592432038.USD","LU0980610538.SGD","LU1815336760.USD","GOOGL","LU2065171311.SGD","IE00B7KXQ091.USD","LU0314106906.USD","LU1778281490.HKD","LU0158827948.USD","LU2552382132.HKD","LU1201861165.SGD","LU0823421416.USD","USJW.SI","SG9999001077.SGD","LU1035773651.USD","LU0314104364.USD","BK4533","LU0672654240.SGD","LU1923623000.USD","LU2111349929.HKD","LU1316542783.SGD","LU1366192091.USD"],"gpt_icon":0},{"id":"2517439514","title":"Costco Shares Down About 4% After Q2 Profit Miss","url":"https://stock-news.laohu8.com/highlight/detail?id=2517439514","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517439514?lang=en_us&edition=fundamental","pubTime":"2025-03-07 22:32","pubTimestamp":1741357942,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250307:nFWN3PQ0TI:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1323610961.USD","IE00BZ1G4Q59.USD","LU0820561818.USD","LU0820561909.HKD","LU1035775433.USD","LU1496350171.SGD","BK4533","LU0417517546.SGD","LU0234570918.USD","LU1069344957.HKD","LU1116320901.HKD","LU2237438978.USD","LU0265550946.USD","LU2360032135.SGD","BK4550","LU0079474960.USD","LU0471298694.HKD","LU0385154629.USD","LU0689472784.USD","LU1571399168.USD","LU0943347566.SGD","LU0234572021.USD","LU1116320737.USD","BK4596","LU1066051498.USD","BK4155","BK4585","LU2125154778.USD","BK4588","LU2210150020.SGD","LU0256863811.USD","LU2210149790.SGD","IE00B5TLWC47.USD","LU0265550359.USD","LU0471298777.SGD","LU2360106947.USD","LU1066053197.SGD","BK4504","LU1496350502.SGD","LU2095319765.USD","IE0008368304.USD","COST","IE00BKVL7J92.USD","LU1551013425.SGD","LU2125154935.USD","BK4581","LU1551013342.USD"],"gpt_icon":0},{"id":"2517499439","title":"Analysts’ Top Consumer Goods Picks: Mama’s Creations (MAMA), Walmart (WMT)","url":"https://stock-news.laohu8.com/highlight/detail?id=2517499439","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517499439?lang=en_us&edition=fundamental","pubTime":"2025-03-07 22:30","pubTimestamp":1741357847,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Consumer Goods sector as 2 analysts just weighed in on Mama’s Creations (MAMA – Research Report) and Wa...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-top-consumer-goods-picks-mamas-creations-mama-walmart-wmt?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-top-consumer-goods-picks-mamas-creations-mama-walmart-wmt?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2592432038.USD","LU0314104364.USD","LU0640476718.USD","LU0256863811.USD","WMT","LU1066053197.SGD","LU1814569148.SGD","LU2361045086.USD","LU0149725797.USD","MAMA","LU1069347547.HKD","BK4550","BK4581","LU1116320737.USD","LU0417517546.SGD","LU0256863902.USD","LU2461242641.AUD","LU0211327993.USD","LU2125154935.USD","LU0175139822.USD","LU2750360997.AUD","BK4588","BK4533","LU2471134796.USD","IE0034235188.USD","LU0289960550.SGD","LU2264538146.SGD","LU2430703251.USD","LU0265550946.USD","LU2125154778.USD","BK4596","LU0265550359.USD","BK4155","LU1064131342.USD","LU2361044865.SGD","BK4504","LU1430594728.SGD","LU1066051225.USD","BK4534","BK4597","LU1035773651.USD","BK4585","LU1988902786.USD","LU2360032135.SGD","LU1066051811.HKD","LU2471134523.USD","LU1267930490.SGD","IE000M9KFDE8.USD","LU1585245621.USD","LU1366192091.USD"],"gpt_icon":0},{"id":"2517439492","title":"Analysts Conflicted on These Consumer Cyclical Names: Carvana Co (CVNA), Martinrea International (OtherMRETF) and Amazon (AMZN)","url":"https://stock-news.laohu8.com/highlight/detail?id=2517439492","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517439492?lang=en_us&edition=fundamental","pubTime":"2025-03-07 22:30","pubTimestamp":1741357813,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Consumer Cyclical sector with new ratings on Carvana Co (CVNA – Research Report), Martinrea Internation...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-consumer-cyclical-names-carvana-co-cvna-martinrea-international-othermretf-and-amazon-amzn?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-consumer-cyclical-names-carvana-co-cvna-martinrea-international-othermretf-and-amazon-amzn?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2023251221.USD","LU2552382058.USD","LU2092627202.USD","LU0708994859.HKD","LU1084165304.USD","LU1069344957.HKD","LU0980610538.SGD","LU0823421416.USD","LU1778281490.HKD","LU2552382132.HKD","LU1720051108.HKD","LU1366333091.USD","IE00BJTD4V19.USD","LU2471134796.USD","LU2265009873.SGD","BK4533","CVNA","IE00B775SV38.USD","IE00B7KXQ091.USD","LU1366192091.USD","LU2420271590.USD","LU1316542783.SGD","LU1201861165.SGD","LU2456880835.USD","LU1496350502.SGD","SG9999002232.USD","LU2326559502.SGD","LU2592432038.USD","AMZN","LU0786609619.USD","IE00B19Z8W00.USD","SG9999014880.SGD","LU1235294995.USD","LU0861579265.USD","SG9999001077.SGD","BK4534","SG9999000418.SGD","LU0672654240.SGD","LU2111349929.HKD","LU0096362180.USD","LU1046421795.USD","LU1868837300.USD","LU2357305700.SGD","LU1674673691.USD","LU0640476718.USD","IE00BKPKM429.USD","LU0314104364.USD","USAW.SI","LU0158827948.USD","LU2065171311.SGD"],"gpt_icon":0},{"id":"2517367294","title":"Eli Lilly Says Half of Eczema Patients Achieve Complete Skin Clearance at 3 Years With Ebglyss","url":"https://stock-news.laohu8.com/highlight/detail?id=2517367294","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517367294?lang=en_us&edition=fundamental","pubTime":"2025-03-07 22:28","pubTimestamp":1741357710,"startTime":"0","endTime":"0","summary":"Eli Lilly  said Friday that new results showed that 50% of patients with moderate-to-severe atopic dermatitis, or eczema, achieved completely clear skin at three years after receiving single monthly maintenance injection of Ebglyss.The patients were among the Ebglyss week 16 responders from the monotherapy trials, the company said.Eli Lilly also said 87% achieved or maintained \"almost-clear\" skin at three years with Ebglyss based on data from a long-term extension study.Ebglyss was approved by the US Food and Drug Administration in 2024 as a first-line monotherapy biologic treatment option after topical prescription therapies.The company also said that based on additional studies, Ebglyss improved symptoms such as itch, skin pain and sleep loss due to itch.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0471298777.SGD","LU0354030438.USD","LU1804176565.USD","SG9999015986.USD","SG9999017495.SGD","LU1988902786.USD","LU2264538146.SGD","SGXZ31699556.SGD","LU2265009873.SGD","LU1720051017.SGD","BK4588","LU1551013425.SGD","LU2237443622.USD","LU0256863811.USD","LU1291159041.SGD","LU2491050154.USD","LU2361044865.SGD","IE00BK4W5L77.USD","LU0708995401.HKD","LU2106854487.HKD","LLY","SG9999014906.USD","LU0943347566.SGD","LU1093756325.SGD","LU0882574055.USD","LU2361045086.USD","LU2602419157.SGD","LU0096364046.USD","LU1814569148.SGD","SG9999014880.SGD","BK4581","LU0238689110.USD","LU1551013342.USD","LU2211815571.USD","SG9999014914.USD","LU0354030511.USD","LU0061475181.USD","LU0058720904.USD","IE00BJJMRZ35.SGD","SGXZ99366536.SGD","SG9999001176.USD","LU2491050071.SGD","LU1917777945.USD","IE00BFTCPJ56.SGD","BK4533","LU0106261372.USD","BK4599","LU2089984988.USD","LU0640476718.USD","LU2360106947.USD"],"gpt_icon":1},{"id":"2517394974","title":"Microsoft testng OpenAI alternatives for Copilot, The Information reports","url":"https://stock-news.laohu8.com/highlight/detail?id=2517394974","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517394974?lang=en_us&edition=fundamental","pubTime":"2025-03-07 22:22","pubTimestamp":1741357377,"startTime":"0","endTime":"0","summary":"Microsoft (MSFT) is testing OpenAI alternatives for Copilot, The Information’s Aaron Holmes reports. The company is currently testing models from x...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/microsoft-testng-openai-alternatives-for-copilot-the-information-reports?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/microsoft-testng-openai-alternatives-for-copilot-the-information-reports?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00BKPKM429.USD","LU1059921491.USD","LU1301847155.USD","IE00B775SV38.USD","SG9999001077.SGD","LU1069344957.HKD","BK4588","LU1571399168.USD","LU0672654240.SGD","LU0124676726.USD","SG9999002232.USD","IE00B5949003.HKD","IE00BLSP4452.SGD","LU0256863811.USD","LU0094547139.USD","LU1674673691.USD","BK4533","LU0792757196.USD","LU0158827948.USD","LU1267930573.SGD","LU1323610961.USD","LU2244417387.USD","LU0314106906.USD","MSFT","LU1236620750.USD","LU1778281490.HKD","LU2420271590.USD","III","LU2413666699.HKD","IE00BJTD4V19.USD","SG9999015358.SGD","LU1815336760.USD","BK4534","LU1035773651.USD","LU0314104364.USD","LU0640476718.USD","BK4504","LU2456880835.USD","IE00B19Z8W00.USD","IE000YTNTUN2.SGD","LU1316542783.SGD","LU2265009873.SGD","LU0823421416.USD","LU0081259029.USD","LU2111349929.HKD","IE00BFSS7M15.SGD","LU0289961442.SGD","LU1496350502.SGD","SG9999014914.USD","LU1046421795.USD"],"gpt_icon":0},{"id":"2517087432","title":"SLDB Stock Rallies 60% in a Month: Here's What You Should Know","url":"https://stock-news.laohu8.com/highlight/detail?id=2517087432","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517087432?lang=en_us&edition=fundamental","pubTime":"2025-03-07 22:13","pubTimestamp":1741356780,"startTime":"0","endTime":"0","summary":"Shares of Solid Biosciences SLDB have rallied 59.9% in the past month. The stock price increase was mainly due to positive initial data, announced in mid-Feb, fromthe early to mid-stage study of its next-generation gene therapy product candidate, SGT-003, for treating Duchenne muscular dystrophy .Interim biopsy data reported in the first three participants at day 90 showed an average microdystrophin expression of 110%, as measured by western blot, along with improvements in multiple biomarkers that are indicators of muscle health and resilience.In the past three months, shares of Solid Biosciences have gained 7.6% against the industry’s 1% decline.The initial data readout also showed encouraging early signals of potential cardiac benefit. SGT-003was well-tolerated in the first six DMD patients dosed. Adverse events were mostly mild to moderate in severity and consistent with those typically observed in AAV gene therapy.Currently,Sarepta TherapeuticsSRPT markets Elevidys as the only app","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/sldb-stock-rallies-60-month-141300442.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4007","IE00B2B36J28.USD","LU0320765992.SGD","BK4139","BK4585","IE0002141913.USD","IE00BJT1NW94.SGD","FA","BK4535","LU0109394709.USD","LU0889565916.HKD","03165","IE00B19Z9P08.USD","RHHBY","BIIB","IE00B19Z9Z06.USD","IE00B894F039.SGD","BK4130","IE0009355771.USD","IE00BJJMRZ35.SGD","BK4588","IE00BFTCPJ56.SGD","LU0234570918.USD","BK4539","SLDB","SRPT","BK4533","BK4532"],"gpt_icon":0},{"id":"2517743572","title":"BUZZ-Neumora falls as J&J's setback triggers concerns over depression drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2517743572","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517743572?lang=en_us&edition=fundamental","pubTime":"2025-03-07 22:11","pubTimestamp":1741356694,"startTime":"0","endTime":"0","summary":"BUZZ-Neumora falls as J&J's setback triggers concerns over depression drug Updates** Shares of Neumora Therapeutics NMRA.O fall 11.2% to $1.35 premarket, set to break three-day winning streak","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250307:nL3N3PQ17A:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4534","LU1032466523.USD","LU0203347892.USD","IE00BVYPNV92.GBP","JNJ","LU2430703178.SGD","LU1066053197.SGD","LU1894683348.USD","LU1261432733.SGD","BK4581","IE00B3PB1722.GBP","LU0234570918.USD","BK4504","LU0640476718.USD","LU1221951046.USD","LU1506573853.SGD","LU1732800096.USD","LU2112291526.USD","BK4585","NMRA","LU2430703095.HKD","IE0009355771.USD","LU1585245621.USD","LU1430594728.SGD","LU0058720904.USD","LU1066051498.USD","SF","LU2430703251.USD","LU0114720955.EUR","BK4127","LU1244550494.USD","LU1162221912.USD","LU1732799900.SGD","LU0203345920.USD","BK4588","LU0098860793.USD","BK4532","BK4592","LU0345769128.USD","LU1061106388.HKD","IE00BJJMRZ35.SGD","LU2505996509.AUD","LU1674673428.USD","LU0122379950.USD","LU0795875086.SGD","BK4550","IE00B42XCP33.USD","LU1057294990.SGD","LU1244550221.USD","BK4533"],"gpt_icon":0},{"id":"2517795439","title":"Philip Morris International (PM): One of the Best Stocks to Invest In According to Billionaires","url":"https://stock-news.laohu8.com/highlight/detail?id=2517795439","media":"Insider Monkey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517795439?lang=en_us&edition=fundamental","pubTime":"2025-03-07 22:11","pubTimestamp":1741356682,"startTime":"0","endTime":"0","summary":"We recently compiled a list of the 30 Best Stocks To Invest In According to Billionaires.In this article, we are going to take a look at where Philip Morris International Inc.  stands against the other stocks.Billionaires and top hedge fund managers dominate the market with large investments in leading companies with strong track records and exceptional performance. These investors have large capital and they like to invest in established companies rather than betting on underperformers.The S&P 500 index has reached its all-time highs, achieving returns of over 20% for the second consecutive year post-COVID. Billionaire investor and CEO of Berkshire Hathaway Warren Buffett made a bold move in 2024, selling a record $134 billion of net stock. Buffett’s move has raised concerns for investors and analysts. Historically, when Buffett’s firm becomes a net seller, it’s often followed by below-average market performance. Many believe that this could be a signal of stock market underperformanc","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/philip-morris-international-pm-one-141122502.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0690374961.EUR","LU0053666078.USD","IE000M9KFDE8.USD","BK4585","IE00B1XK9C88.USD","LU0170899867.USD","LU1363072403.SGD","LU0640476718.USD","BK4581","LU0154236417.USD","LU0994945656.USD","LU0661504455.SGD","LU0048573561.USD","LU1066053197.SGD","BK4075","LU0426417589.USD","GB00B4QBRK32.GBP","LU1228905540.USD","LU1280957306.USD","IE0034235303.USD","IE00BK4W5M84.HKD","LU1043141396.HKD","LU1366333091.USD","LU1228905037.USD","LU0742534661.SGD","PM","BK4534","LU1201861249.SGD","IE00BKDWB100.SGD","LU0787776722.HKD","LU1506573853.SGD","LU0130102774.USD","LU0690374615.EUR","LU0949170772.SGD","LU0971096721.USD","GB00B4LPDJ14.GBP","SG9999011175.SGD","LU0683600562.USD","LU1121112475.USD","LU0251131958.USD","LU0234570918.USD","LU0545562505.USD","LU0149725797.USD","LU0980610538.SGD","LU1066051811.HKD","LU0426412945.USD","BK4533","LU0157215616.USD","IE00B775SV38.USD"],"gpt_icon":1},{"id":"2517435593","title":"BRIEF-Humana Says CEO James A. Rechtin's 2024 Total Compensation Was $15.6 Million – SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2517435593","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517435593?lang=en_us&edition=fundamental","pubTime":"2025-03-07 22:02","pubTimestamp":1741356166,"startTime":"0","endTime":"0","summary":"BRIEF-Humana Says CEO James A. Rechtin's 2024 Total Compensation Was $15.6 Million – SEC FilingMarch 7  - Humana Inc HUM.N:HUMANA SAYS CEO JAMES A. RECHTIN'S 2024 TOTAL COMPENSATION WAS $15.6 MILLION – SEC FILINGSource text: [ID:n0001193125-25-048976]Further company coverage: HUM.N ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250307:nFWN3PQ0FM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4154","LU0266013472.USD","LU0170899867.USD","LU0320765489.SGD","LU0070302665.USD","LU0390134368.USD","BK4533","LU0417517546.SGD","LU0208291251.USD","HUM","LU1093756168.USD","LU0238689110.USD","SG9999014013.SGD","LU0211331839.USD","LU0348723411.USD","SG9999014005.SGD","LU0256863811.USD","BK4566","LU1983260115.SGD","LU1093756325.SGD","SG9999014021.USD","BK4585"],"gpt_icon":0}],"pageSize":16,"totalPage":206,"pageCount":14,"totalSize":3293}]}}